Washington Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Washington Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-49,755	Closed	-$746K	–	134
2016 Q1	$746K	Sell	49,755 -14,642	-23%	-$245K	0.55%	79
2015 Q4	$1.41M	Sell	64,397 -586	-0.9%	-$10.9K	0.88%	51
2015 Q3	$1.02M	Buy	64,983 +2,417	+4%	+$38.7K	0.64%	78
2015 Q2	$894K	Hold	62,566	–	–	0.5%	84
2015 Q1	$1.08M	Sell	62,566 -21,569	-26%	-$381K	0.62%	79
2014 Q4	$1.51M	Buy	+84,135	New	+$1.35M	0.63%	81

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Washington Capital Management's NXTM Position: Q2 2016 in Review

Washington Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 49,755 shares — an estimated $746K sold.

Washington Capital Management first reported a position in NXTM in Q4 2014 and held it in 6 quarters. The position peaked at $1.51M in Q4 2014. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

Washington Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
Washington Capital Management sold 49,755 NxStage Medical Inc. shares in Q2 2016, an estimated $746K.
Washington Capital Management first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 6 quarters.
Washington Capital Management's NxStage Medical Inc. position peaked at $1.51M in Q4 2014.
147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on Washington Capital Management's 13F filing for Q2 2016, filed 5 Aug 2016.